Gene · 406941
Papers2,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of The circ-HIPK3, circ-PVT1, miR-25, and miR-149 in Response of Breast Cancer Cells to Ionizing Radiation. | Cell J | 2023 | 37865877 | PubTator, text mining | PubMed |
| MiR-199a-5p Decreases Esophageal Cancer Cell Proliferation Partially through Repression of Jun-B. | Cancers (Basel) | 2023 | 37835506 | PubTator, text mining | PubMed |
| Ethanolic Extract of Propolis Modulates Autophagy-Related microRNAs in Osteoarthritic Chondrocytes. | Int J Mol Sci | 2023 | 37834215 | PubTator, text mining | PubMed |
| The crosstalk between non-coding RNA polymorphisms and resistance to lung cancer therapies. | Heliyon | 2023 | 37829813 | PubTator, text mining | PubMed |
| Characterization of the lncRNA-mediated ceRNA regulatory networks in preeclampsia by integrated bioinformatics. | Sci Rep | 2023 | 37828060 | PubTator, text mining | PubMed |
| LncRNA PVT1 induces apoptosis and inflammatory response of bronchial epithelial cells by regulating miR-30b-5p/BCL2L11 axis in COPD. | Genes Environ | 2023 | 37817266 | PubTator, text mining | PubMed |
| Hedgehog pathway in sarcoma: from preclinical mechanism to clinical application. | J Cancer Res Clin Oncol | 2023 | 37815662 | PubTator, text mining | PubMed |
| Arf6 as a therapeutic target: Structure, mechanism, and inhibitors. | Acta Pharm Sin B | 2023 | 37799386 | PubTator, text mining | PubMed |
| The Role of Adipocyte Endoplasmic Reticulum Stress in Obese Adipose Tissue Dysfunction: A Review. | Int J Gen Med | 2023 | 37789878 | PubTator, text mining | PubMed |
| Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. | Mol Cancer | 2023 | 37784082 | PubTator, text mining | PubMed |
| The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors. | Int J Biol Sci | 2023 | 37781524 | PubTator, text mining | PubMed |
| MKL-1 suppresses ferroptosis by activating system Xc- and increasing glutathione synthesis. | Int J Biol Sci | 2023 | 37781038 | PubTator, text mining | PubMed |
| The emerging role of lncRNAs in osteoarthritis development and potential therapy. | Front Genet | 2023 | 37779916 | PubTator, text mining | PubMed |
| Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis. | Cell Mol Biol Lett | 2023 | 37770821 | PubTator, text mining | PubMed |
| Does the Necrotic Portion of Metastatic Lymphadenopathy from Squamous Cell Carcinoma Still Have Tumoral Oncologic Information? Differential Diagnosis of Benign Necrotic Lymphadenopathy Using microRNA. | Biomedicines | 2023 | 37760848 | PubTator, text mining | PubMed |
| Association of miR-149 T>C and miR-196a2 C>T Polymorphisms with Colorectal Cancer Susceptibility: A Case-Control Study. | Biomedicines | 2023 | 37760783 | PubTator, text mining | PubMed |
| Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis. | Cancers (Basel) | 2023 | 37760534 | PubTator, text mining | PubMed |
| MicroRNAs in the Regulation of RIG-I-like Receptor Signaling Pathway: Possible Strategy for Viral Infection and Cancer. | Biomolecules | 2023 | 37759744 | PubTator, text mining | PubMed |
| Update on the association of miR-149 rs2292832 C>T polymorphism with gastric cancer risk: A meta-analysis study of gastrointestinal cancers. | Medicine (Baltimore) | 2023 | 37747007 | PubTator, text mining | PubMed |
| CircUCP2 promotes the tumor progression of non-small cell lung cancer through the miR-149/UCP2 pathway. | Oncol Res | 2023 | 37744277 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406941/papers?page=7